As part of the agreement, the beer giant will manage the sales, distribution and production of Fevertree’s products in the US ...

(Reuters) -Shares of Fevertree Drinks surged almost 24% after Molson Coors took an 8.5% stake in a $88 million deal that ...

By Shashwat Awasthi (Reuters) -Shares of Fevertree Drinks surged almost 24% after Molson Coors' took an 8.5% stake in the ...

Molson Coors Beverage Company has announced a strategic partnership with Fever-Tree in the US, aiming to fuel its ...

Wells Fargo analyst Christopher Carey maintained a Buy rating on Molson Coors (TAP – Research Report) yesterday and set a price target of ...

The deal gives Molson Coors exclusive commercialization rights to Fever-Tree’s U.S. portfolio, alongside an equity investment by Molson Coors into Fevertree Drinks plc Partnership designed to fuel ...

Molson Coors has acquired an 8.5% stake in British drinks company Fever Tree in a £71m deal that enables the mixer brand to ...

US brewer Molson Coors is to buy an 8.5% stake in Fevertree for £71m, with the proceeds to be returned to shareholders via a ...

CLEANING toilets and selling paraffin isn’t the usual path to becoming a CEO. But that was the route for Neil Clifford, who ...

In a report released today, Bill Kirk from Roth MKM maintained a Buy rating on High Tide (HITI – Research Report), with a price target of ...

The Coors Light brewer will pay £71 million ($88 million) for 8.5% of Fevertree, a move that will help the Chicago-based company expand its non-alcoholic range.

Kromek Group left investors cheering this week as it unmasked a road to profitability via a deal with Siemens Healthineers.